Parametric Portfolio Associates’s Revance Therapeutics, Inc. RVNC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $5.41M | Sell |
277,250
-90,482
| -25% | -$1.76M | ﹤0.01% | 1797 |
|
2021
Q4 | $6M | Buy |
367,732
+98,664
| +37% | +$1.61M | ﹤0.01% | 1732 |
|
2021
Q3 | $7.5M | Buy |
269,068
+667
| +0.2% | +$18.6K | ﹤0.01% | 1547 |
|
2021
Q2 | $7.96M | Buy |
268,401
+7,748
| +3% | +$230K | ﹤0.01% | 1548 |
|
2021
Q1 | $7.29M | Buy |
260,653
+959
| +0.4% | +$26.8K | ﹤0.01% | 1903 |
|
2020
Q4 | $7.36M | Sell |
259,694
-36,497
| -12% | -$1.03M | ﹤0.01% | 1813 |
|
2020
Q3 | $7.45M | Buy |
296,191
+42,801
| +17% | +$1.08M | 0.01% | 1593 |
|
2020
Q2 | $6.19M | Sell |
253,390
-16,189
| -6% | -$395K | ﹤0.01% | 1729 |
|
2020
Q1 | $3.99M | Sell |
269,579
-67,150
| -20% | -$994K | ﹤0.01% | 1903 |
|
2019
Q4 | $5.47M | Buy |
336,729
+81,921
| +32% | +$1.33M | ﹤0.01% | 2005 |
|
2019
Q3 | $3.31M | Buy |
254,808
+143,593
| +129% | +$1.87M | ﹤0.01% | 2321 |
|
2019
Q2 | $1.44M | Buy |
111,215
+53,810
| +94% | +$698K | ﹤0.01% | 2855 |
|
2019
Q1 | $905K | Buy |
57,405
+4,787
| +9% | +$75.5K | ﹤0.01% | 3080 |
|
2018
Q4 | $1.06M | Buy |
52,618
+5,784
| +12% | +$116K | ﹤0.01% | 2948 |
|
2018
Q3 | $1.16M | Buy |
46,834
+9,429
| +25% | +$234K | ﹤0.01% | 3009 |
|
2018
Q2 | $1.03M | Sell |
37,405
-35,444
| -49% | -$973K | ﹤0.01% | 3040 |
|
2018
Q1 | $2.24M | Sell |
72,849
-6
| -0% | -$185 | ﹤0.01% | 2539 |
|
2017
Q4 | $2.61M | Buy |
72,855
+37,808
| +108% | +$1.35M | ﹤0.01% | 2423 |
|
2017
Q3 | $966K | Buy |
35,047
+5,935
| +20% | +$164K | ﹤0.01% | 3067 |
|
2017
Q2 | $769K | Buy |
29,112
+1,711
| +6% | +$45.2K | ﹤0.01% | 3125 |
|
2017
Q1 | $570K | Buy |
27,401
+1,524
| +6% | +$31.7K | ﹤0.01% | 3135 |
|
2016
Q4 | $536K | Buy |
25,877
+5,040
| +24% | +$104K | ﹤0.01% | 3151 |
|
2016
Q3 | $338K | Sell |
20,837
-231
| -1% | -$3.75K | ﹤0.01% | 3363 |
|
2016
Q2 | $287K | Sell |
21,068
-1,856
| -8% | -$25.3K | ﹤0.01% | 3466 |
|
2016
Q1 | $400K | Buy |
+22,924
| New | +$400K | ﹤0.01% | 3446 |
|